Liposomal bupivacaine is one of 145 small molecule programs targeting Total Joint Arthroplasty. It is currently in Phase 3.
Indications
Total Trials
Active Trials
Competitors
Pipeline
Competition
77 competitors in Chronic Pain
Xylocaine
Duragesic
Suboxone
Intuniv
Marcaine
Tylenol
Dilaudid
Advil
Versed
Bendopa
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Clinical
Sources
Details